Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Organon & Co. (OGN)

Organon & Co. (OGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
3 Healthcare Stocks with Questionable Fundamentals

3 Healthcare Stocks with Questionable Fundamentals

OGN : 7.18 (+1.27%)
SEM : 14.77 (-0.47%)
AMPH : 27.12 (+1.16%)
Why Organon (OGN) Shares Are Trading Lower Today

Why Organon (OGN) Shares Are Trading Lower Today

OGN : 7.18 (+1.27%)
3 Stocks Under $10 We Steer Clear Of

3 Stocks Under $10 We Steer Clear Of

VSTS : 6.55 (-2.82%)
OGN : 7.18 (+1.27%)
NEOG : 7.13 (-0.14%)
3 Value Stocks with Questionable Fundamentals

3 Value Stocks with Questionable Fundamentals

IRDM : 17.21 (-1.09%)
ANGI : 12.66 (-0.47%)
OGN : 7.18 (+1.27%)
3 Cash-Producing Stocks We Find Risky

3 Cash-Producing Stocks We Find Risky

HLMN : 9.09 (+1.11%)
OGN : 7.18 (+1.27%)
REGN : 784.97 (+0.16%)
Organon (OGN): Buy, Sell, or Hold Post Q3 Earnings?

Organon (OGN): Buy, Sell, or Hold Post Q3 Earnings?

OGN : 7.18 (+1.27%)
Q3 Rundown: Organon (NYSE:OGN) Vs Other Branded Pharmaceuticals Stocks

Q3 Rundown: Organon (NYSE:OGN) Vs Other Branded Pharmaceuticals Stocks

OGN : 7.18 (+1.27%)
Organon To Present at the Piper Sandler 37th Annual Healthcare Conference

Organon (NYSE: OGN), announced today that Joe Morrissey, Interim Chief Executive Officer, and Matthew Walsh, Chief Financial Officer, are scheduled to participate in a fireside chat at the Piper Sandler...

OGN : 7.18 (+1.27%)
Henlius and Organon Announce US FDA Approval of POHERDY® (pertuzumab-dpzb), the First PERJETA (pertuzumab) Biosimilar in the US

Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced that the US Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for POHERDY ...

OGN : 7.18 (+1.27%)
The 5 Most Interesting Analyst Questions From Organon’s Q3 Earnings Call

The 5 Most Interesting Analyst Questions From Organon’s Q3 Earnings Call

OGN : 7.18 (+1.27%)

Barchart Exclusives

Tesla + Robinhood + FedEx’s Unusually Active Put Options Could Deliver $Big Income Over the Next 30 Days
In the past 30 days, Tesla, Robinhood, and FedEx’s unusually active put options generated big income. Looking out 30 days, here’s how the three stocks can keep the income flowing. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar